Rank | Gene Set | Z-score |
---|---|---|
1 | DNA strand renaturation (GO:0000733) | 5.66526393 |
2 | negative regulation of cell aging (GO:0090344) | 4.76281683 |
3 | meiotic chromosome segregation (GO:0045132) | 4.67035286 |
4 | NADH metabolic process (GO:0006734) | 4.46754956 |
5 | nucleobase biosynthetic process (GO:0046112) | 4.40404319 |
6 | mitotic metaphase plate congression (GO:0007080) | 4.37689873 |
7 | N-acetylneuraminate metabolic process (GO:0006054) | 4.30930946 |
8 | proteasome assembly (GO:0043248) | 4.22277669 |
9 | purine nucleobase biosynthetic process (GO:0009113) | 4.17919756 |
10 | GDP-mannose metabolic process (GO:0019673) | 4.16508253 |
11 | DNA deamination (GO:0045006) | 4.15128797 |
12 | rRNA methylation (GO:0031167) | 4.14016159 |
13 | rRNA modification (GO:0000154) | 4.11706241 |
14 | tricarboxylic acid cycle (GO:0006099) | 4.06200798 |
15 | oxaloacetate metabolic process (GO:0006107) | 4.02416234 |
16 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.93797764 |
17 | cullin deneddylation (GO:0010388) | 3.93057554 |
18 | regulation of protein heterodimerization activity (GO:0043497) | 3.92194150 |
19 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.90797177 |
20 | protein deneddylation (GO:0000338) | 3.87151011 |
21 | ribosomal small subunit assembly (GO:0000028) | 3.86719223 |
22 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.86403484 |
23 | regulation of skeletal muscle contraction (GO:0014819) | 3.78020733 |
24 | respiratory chain complex IV assembly (GO:0008535) | 3.75160509 |
25 | regulation of oxidative phosphorylation (GO:0002082) | 3.73061338 |
26 | metaphase plate congression (GO:0051310) | 3.70911328 |
27 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.68180060 |
28 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.66743711 |
29 | NADH dehydrogenase complex assembly (GO:0010257) | 3.66743711 |
30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.66743711 |
31 | protein complex biogenesis (GO:0070271) | 3.65773852 |
32 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.65461547 |
33 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.62453962 |
34 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.60911061 |
35 | regulation of RIG-I signaling pathway (GO:0039535) | 3.60806169 |
36 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.60789475 |
37 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.52459161 |
38 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.51860834 |
39 | DNA strand elongation (GO:0022616) | 3.48228931 |
40 | purine-containing compound salvage (GO:0043101) | 3.47594471 |
41 | DNA synthesis involved in DNA repair (GO:0000731) | 3.45464659 |
42 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.45209906 |
43 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.44323746 |
44 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.44234453 |
45 | amino acid salvage (GO:0043102) | 3.42669272 |
46 | L-methionine salvage (GO:0071267) | 3.42669272 |
47 | L-methionine biosynthetic process (GO:0071265) | 3.42669272 |
48 | cytochrome complex assembly (GO:0017004) | 3.42633486 |
49 | protein localization to chromosome, centromeric region (GO:0071459) | 3.39814624 |
50 | peptidyl-arginine N-methylation (GO:0035246) | 3.39548562 |
51 | peptidyl-arginine methylation (GO:0018216) | 3.39548562 |
52 | inositol phosphate dephosphorylation (GO:0046855) | 3.38323206 |
53 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.38323206 |
54 | DNA replication checkpoint (GO:0000076) | 3.37542813 |
55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.34284883 |
56 | establishment of viral latency (GO:0019043) | 3.33499856 |
57 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.33242309 |
58 | maturation of 5.8S rRNA (GO:0000460) | 3.32298486 |
59 | inositol phosphate catabolic process (GO:0071545) | 3.30269187 |
60 | purine nucleotide salvage (GO:0032261) | 3.29897092 |
61 | establishment of chromosome localization (GO:0051303) | 3.28140294 |
62 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.27760106 |
63 | DNA replication initiation (GO:0006270) | 3.24937161 |
64 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.24659412 |
65 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.24659412 |
66 | negative regulation of ligase activity (GO:0051352) | 3.24614527 |
67 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.24614527 |
68 | mitotic sister chromatid segregation (GO:0000070) | 3.23632450 |
69 | oxidative phosphorylation (GO:0006119) | 3.22945036 |
70 | formation of translation preinitiation complex (GO:0001731) | 3.22925393 |
71 | DNA double-strand break processing (GO:0000729) | 3.20984646 |
72 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.19576900 |
73 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.19576900 |
74 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.19576900 |
75 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.19085897 |
76 | nuclear envelope organization (GO:0006998) | 3.17272376 |
77 | IMP biosynthetic process (GO:0006188) | 3.17184631 |
78 | mitotic cell cycle arrest (GO:0071850) | 3.17176676 |
79 | DNA ligation (GO:0006266) | 3.16505931 |
80 | establishment of integrated proviral latency (GO:0075713) | 3.16500401 |
81 | proline biosynthetic process (GO:0006561) | 3.15513493 |
82 | ribosome assembly (GO:0042255) | 3.14593920 |
83 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.10584159 |
84 | telomere maintenance via recombination (GO:0000722) | 3.09797239 |
85 | pyrimidine dimer repair (GO:0006290) | 3.09219263 |
86 | DNA duplex unwinding (GO:0032508) | 3.09203373 |
87 | purine ribonucleotide transport (GO:0015868) | 3.09084237 |
88 | base-excision repair (GO:0006284) | 3.07832718 |
89 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.07448847 |
90 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.07448847 |
91 | protein K11-linked ubiquitination (GO:0070979) | 3.07018416 |
92 | adenosine receptor signaling pathway (GO:0001973) | 3.04660465 |
93 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.03947740 |
94 | snRNA metabolic process (GO:0016073) | 3.03038267 |
95 | histone H2A acetylation (GO:0043968) | 3.02141190 |
96 | positive regulation of interferon-alpha production (GO:0032727) | 3.01015938 |
97 | mismatch repair (GO:0006298) | 3.00869240 |
98 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.00757804 |
99 | DNA geometric change (GO:0032392) | 2.99053343 |
100 | protein-cofactor linkage (GO:0018065) | 2.98170399 |
101 | succinate metabolic process (GO:0006105) | 2.97988532 |
102 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.97854002 |
103 | mitotic nuclear envelope disassembly (GO:0007077) | 2.97275987 |
104 | nucleotide transmembrane transport (GO:1901679) | 2.96369628 |
105 | mitochondrial fusion (GO:0008053) | 2.96202796 |
106 | adenine nucleotide transport (GO:0051503) | 2.93973477 |
107 | 7-methylguanosine mRNA capping (GO:0006370) | 2.93181961 |
108 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.92950257 |
109 | mitotic recombination (GO:0006312) | 2.92470908 |
110 | RNA capping (GO:0036260) | 2.90088788 |
111 | 7-methylguanosine RNA capping (GO:0009452) | 2.90088788 |
112 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.90014320 |
113 | protein localization to chromosome (GO:0034502) | 2.89262097 |
114 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.87039993 |
115 | type B pancreatic cell proliferation (GO:0044342) | 2.86533638 |
116 | nuclear envelope disassembly (GO:0051081) | 2.86179364 |
117 | membrane disassembly (GO:0030397) | 2.86179364 |
118 | DNA unwinding involved in DNA replication (GO:0006268) | 2.85445233 |
119 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.85432601 |
120 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.84849250 |
121 | mRNA cleavage (GO:0006379) | 2.83618489 |
122 | sister chromatid segregation (GO:0000819) | 2.82441406 |
123 | mitochondrial DNA metabolic process (GO:0032042) | 2.82118024 |
124 | nuclear pore complex assembly (GO:0051292) | 2.81767079 |
125 | UV protection (GO:0009650) | 2.81702845 |
126 | mitotic sister chromatid cohesion (GO:0007064) | 2.80700524 |
127 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.79359720 |
128 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.79359720 |
129 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.79254520 |
130 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.78566396 |
131 | snRNA processing (GO:0016180) | 2.76772675 |
132 | positive regulation of ligase activity (GO:0051351) | 2.76049857 |
133 | aerobic respiration (GO:0009060) | 2.75678045 |
134 | regulation of interferon-alpha production (GO:0032647) | 2.75441988 |
135 | IMP metabolic process (GO:0046040) | 2.72631024 |
136 | mitochondrial DNA replication (GO:0006264) | 2.72555609 |
137 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.70347375 |
138 | quinone biosynthetic process (GO:1901663) | 2.69652881 |
139 | ubiquinone biosynthetic process (GO:0006744) | 2.69652881 |
140 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.69048904 |
141 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.69048904 |
142 | ATP synthesis coupled proton transport (GO:0015986) | 2.68675575 |
143 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.68675575 |
144 | synapsis (GO:0007129) | 2.68300912 |
145 | metallo-sulfur cluster assembly (GO:0031163) | 2.68264067 |
146 | iron-sulfur cluster assembly (GO:0016226) | 2.68264067 |
147 | branched-chain amino acid catabolic process (GO:0009083) | 2.68147581 |
148 | lipid particle organization (GO:0034389) | 2.67976702 |
149 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.67832079 |
150 | Golgi transport vesicle coating (GO:0048200) | 2.67545181 |
151 | COPI coating of Golgi vesicle (GO:0048205) | 2.67545181 |
152 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.66075279 |
153 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.66075279 |
154 | negative regulation of bone mineralization (GO:0030502) | 2.65773106 |
155 | intra-S DNA damage checkpoint (GO:0031573) | 2.65704197 |
156 | tRNA aminoacylation for protein translation (GO:0006418) | 2.65390151 |
157 | regulation of spindle organization (GO:0090224) | 2.65298282 |
158 | purine nucleobase metabolic process (GO:0006144) | 2.64955286 |
159 | positive regulation of mitochondrial fission (GO:0090141) | 2.64754427 |
160 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.63641483 |
161 | termination of RNA polymerase III transcription (GO:0006386) | 2.63641483 |
162 | lens fiber cell differentiation (GO:0070306) | 2.63628712 |
163 | chaperone-mediated protein transport (GO:0072321) | 2.63246117 |
164 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.62883843 |
165 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.62883843 |
166 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.62883843 |
167 | glycolytic process (GO:0006096) | 2.61617608 |
168 | amino acid activation (GO:0043038) | 2.61386057 |
169 | tRNA aminoacylation (GO:0043039) | 2.61386057 |
170 | DNA integration (GO:0015074) | 2.61378912 |
171 | CENP-A containing nucleosome assembly (GO:0034080) | 2.61145832 |
172 | nucleoside salvage (GO:0043174) | 2.60318592 |
173 | spindle checkpoint (GO:0031577) | 2.59879406 |
174 | negative regulation of DNA recombination (GO:0045910) | 2.59807025 |
175 | pore complex assembly (GO:0046931) | 2.59115586 |
176 | microtubule depolymerization (GO:0007019) | 2.57860201 |
177 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.56283020 |
178 | sialylation (GO:0097503) | 2.55828410 |
179 | mitotic spindle checkpoint (GO:0071174) | 2.55108852 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.13289428 |
2 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.26072662 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.09717475 |
4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.99836389 |
5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.67583210 |
6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.60809032 |
7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.52781973 |
8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.50179075 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.37805386 |
10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.32110250 |
11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.31622593 |
12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.29024894 |
13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.00990669 |
14 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.87952932 |
15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.86642875 |
16 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.68240202 |
17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.51159098 |
18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.46295605 |
19 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.43963358 |
20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42742056 |
21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35276112 |
22 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.34471155 |
23 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.34352754 |
24 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.30146845 |
25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.23628275 |
26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.22465260 |
27 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21541996 |
28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18242993 |
29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16852713 |
30 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.06406069 |
31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06210861 |
32 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.05692129 |
33 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.03628600 |
34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.97798901 |
35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.97115536 |
36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.96415560 |
37 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.96193753 |
38 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90867928 |
39 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.89214067 |
40 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.86673206 |
41 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.85690240 |
42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82957212 |
43 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.81968243 |
44 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.81853938 |
45 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81759615 |
46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79795252 |
47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.78548829 |
48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.75405570 |
49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.74452631 |
50 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.74191106 |
51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.72947555 |
52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70512751 |
53 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66112767 |
54 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.66102483 |
55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.64535466 |
56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.61920430 |
57 | MAF_26560356_Chip-Seq_TH2_Human | 1.60714136 |
58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58406172 |
59 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.57995381 |
60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.54800279 |
61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54500370 |
62 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.53625219 |
63 | MAF_26560356_Chip-Seq_TH1_Human | 1.49688610 |
64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43578313 |
65 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42772356 |
66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41893041 |
67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41054236 |
68 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.40199903 |
69 | P68_20966046_ChIP-Seq_HELA_Human | 1.39814091 |
70 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.38034002 |
71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.35296262 |
72 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.34664715 |
73 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31982443 |
74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30301559 |
75 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.28581309 |
76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28057176 |
77 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.27611007 |
78 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27142762 |
79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26210165 |
80 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20889803 |
81 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.20331941 |
82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19771238 |
83 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.19082689 |
84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18516161 |
85 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.18476505 |
86 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16892780 |
87 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16715652 |
88 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16521529 |
89 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13762946 |
90 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.13027423 |
91 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11952368 |
92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06338241 |
93 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05311680 |
94 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05079345 |
95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04080098 |
96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03869667 |
97 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03707336 |
98 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02875631 |
99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02301727 |
100 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99948537 |
101 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99853988 |
102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.99193731 |
103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98862996 |
104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98502232 |
105 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98493931 |
106 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.98326634 |
107 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98268919 |
108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96563879 |
109 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.96140477 |
110 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94486219 |
111 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94411356 |
112 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88570283 |
113 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88191986 |
114 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87611578 |
115 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.87029092 |
116 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86766236 |
117 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86737937 |
118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.86365921 |
119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86362369 |
120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86159549 |
121 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85692777 |
122 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.84716243 |
123 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84496324 |
124 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81203726 |
125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81158014 |
126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79969349 |
127 | MYC_22102868_ChIP-Seq_BL_Human | 0.79099845 |
128 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77227066 |
129 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.73918300 |
130 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.73274861 |
131 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.73068548 |
132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.69680785 |
133 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.68788351 |
134 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.68541124 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009697_abnormal_copulation | 4.15752656 |
2 | MP0005423_abnormal_somatic_nervous | 3.37184732 |
3 | MP0000751_myopathy | 3.30411433 |
4 | MP0000372_irregular_coat_pigmentation | 3.04689754 |
5 | MP0005083_abnormal_biliary_tract | 2.93775158 |
6 | MP0001986_abnormal_taste_sensitivity | 2.81905859 |
7 | MP0003123_paternal_imprinting | 2.81031673 |
8 | MP0005174_abnormal_tail_pigmentation | 2.80434306 |
9 | MP0003136_yellow_coat_color | 2.66768392 |
10 | MP0005075_abnormal_melanosome_morpholog | 2.64704264 |
11 | MP0003879_abnormal_hair_cell | 2.64443063 |
12 | MP0002876_abnormal_thyroid_physiology | 2.54835468 |
13 | MP0008057_abnormal_DNA_replication | 2.42185451 |
14 | MP0004147_increased_porphyrin_level | 2.39307468 |
15 | MP0009333_abnormal_splenocyte_physiolog | 2.28724487 |
16 | MP0001348_abnormal_lacrimal_gland | 2.24488774 |
17 | MP0008877_abnormal_DNA_methylation | 2.22411511 |
18 | MP0006036_abnormal_mitochondrial_physio | 2.20460610 |
19 | MP0005408_hypopigmentation | 2.14773438 |
20 | MP0010094_abnormal_chromosome_stability | 2.14036386 |
21 | MP0003693_abnormal_embryo_hatching | 2.13101884 |
22 | MP0008058_abnormal_DNA_repair | 2.11587616 |
23 | MP0005671_abnormal_response_to | 2.10487050 |
24 | MP0001346_abnormal_lacrimal_gland | 2.03210163 |
25 | MP0005085_abnormal_gallbladder_physiolo | 2.00760258 |
26 | MP0005365_abnormal_bile_salt | 2.00611184 |
27 | MP0004957_abnormal_blastocyst_morpholog | 1.98647087 |
28 | MP0003646_muscle_fatigue | 1.97970380 |
29 | MP0001764_abnormal_homeostasis | 1.95046964 |
30 | MP0003806_abnormal_nucleotide_metabolis | 1.89587503 |
31 | MP0003186_abnormal_redox_activity | 1.89476177 |
32 | MP0001661_extended_life_span | 1.86303101 |
33 | MP0006035_abnormal_mitochondrial_morpho | 1.81688342 |
34 | MP0002736_abnormal_nociception_after | 1.81456823 |
35 | MP0002139_abnormal_hepatobiliary_system | 1.80200190 |
36 | MP0008007_abnormal_cellular_replicative | 1.77858929 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.75529084 |
38 | MP0001545_abnormal_hematopoietic_system | 1.75529084 |
39 | MP0002396_abnormal_hematopoietic_system | 1.72521082 |
40 | MP0008260_abnormal_autophagy | 1.69047493 |
41 | MP0002822_catalepsy | 1.66797868 |
42 | MP0000750_abnormal_muscle_regeneration | 1.64636650 |
43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.63888214 |
44 | MP0000747_muscle_weakness | 1.63634520 |
45 | MP0003077_abnormal_cell_cycle | 1.63195410 |
46 | MP0003221_abnormal_cardiomyocyte_apopto | 1.60786072 |
47 | MP0003787_abnormal_imprinting | 1.57206080 |
48 | MP0003011_delayed_dark_adaptation | 1.56133743 |
49 | MP0005501_abnormal_skin_physiology | 1.54733976 |
50 | MP0005360_urolithiasis | 1.51338630 |
51 | MP0003718_maternal_effect | 1.47951643 |
52 | MP0004142_abnormal_muscle_tone | 1.47163743 |
53 | MP0003453_abnormal_keratinocyte_physiol | 1.46809203 |
54 | MP0002160_abnormal_reproductive_system | 1.46248216 |
55 | MP0005623_abnormal_meninges_morphology | 1.45182618 |
56 | MP0009046_muscle_twitch | 1.43185725 |
57 | MP0000013_abnormal_adipose_tissue | 1.42882853 |
58 | MP0001968_abnormal_touch/_nociception | 1.42286470 |
59 | MP0001529_abnormal_vocalization | 1.40290270 |
60 | MP0003656_abnormal_erythrocyte_physiolo | 1.39575299 |
61 | MP0009785_altered_susceptibility_to | 1.37240942 |
62 | MP0004197_abnormal_fetal_growth/weight/ | 1.32083233 |
63 | MP0004782_abnormal_surfactant_physiolog | 1.32061045 |
64 | MP0000015_abnormal_ear_pigmentation | 1.32043938 |
65 | MP0009840_abnormal_foam_cell | 1.31208731 |
66 | MP0002080_prenatal_lethality | 1.28942652 |
67 | MP0002132_abnormal_respiratory_system | 1.28381266 |
68 | MP0005451_abnormal_body_composition | 1.27994644 |
69 | MP0005330_cardiomyopathy | 1.27930240 |
70 | MP0001835_abnormal_antigen_presentation | 1.27679048 |
71 | MP0003122_maternal_imprinting | 1.26502791 |
72 | MP0010329_abnormal_lipoprotein_level | 1.26436329 |
73 | MP0000689_abnormal_spleen_morphology | 1.26192562 |
74 | MP0003763_abnormal_thymus_physiology | 1.25383262 |
75 | MP0000681_abnormal_thyroid_gland | 1.24959433 |
76 | MP0000490_abnormal_crypts_of | 1.23488781 |
77 | MP0003111_abnormal_nucleus_morphology | 1.19558649 |
78 | MP0000313_abnormal_cell_death | 1.19063973 |
79 | MP0000350_abnormal_cell_proliferation | 1.18243999 |
80 | MP0003183_abnormal_peptide_metabolism | 1.17432321 |
81 | MP0006292_abnormal_olfactory_placode | 1.16750529 |
82 | MP0001905_abnormal_dopamine_level | 1.15180744 |
83 | MP0002398_abnormal_bone_marrow | 1.12110768 |
84 | MP0001672_abnormal_embryogenesis/_devel | 1.10128672 |
85 | MP0005380_embryogenesis_phenotype | 1.10128672 |
86 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09892179 |
87 | MP0003121_genomic_imprinting | 1.09742471 |
88 | MP0006054_spinal_hemorrhage | 1.09118692 |
89 | MP0005646_abnormal_pituitary_gland | 1.08299738 |
90 | MP0005636_abnormal_mineral_homeostasis | 1.07214500 |
91 | MP0004233_abnormal_muscle_weight | 1.07046680 |
92 | MP0002722_abnormal_immune_system | 1.05701586 |
93 | MP0005389_reproductive_system_phenotype | 1.05568408 |
94 | MP0003786_premature_aging | 1.03367158 |
95 | MP0008995_early_reproductive_senescence | 1.03142668 |
96 | MP0000749_muscle_degeneration | 1.00930949 |
97 | MP0001697_abnormal_embryo_size | 1.00607194 |
98 | MP0005332_abnormal_amino_acid | 1.00352991 |
99 | MP0003880_abnormal_central_pattern | 0.99446662 |
100 | MP0001243_abnormal_dermal_layer | 0.98769114 |
101 | MP0003984_embryonic_growth_retardation | 0.98387812 |
102 | MP0001188_hyperpigmentation | 0.98190090 |
103 | MP0002638_abnormal_pupillary_reflex | 0.97587832 |
104 | MP0001502_abnormal_circadian_rhythm | 0.96856884 |
105 | MP0005384_cellular_phenotype | 0.96240664 |
106 | MP0008789_abnormal_olfactory_epithelium | 0.96177515 |
107 | MP0005319_abnormal_enzyme/_coenzyme | 0.96084588 |
108 | MP0005621_abnormal_cell_physiology | 0.94066878 |
109 | MP0005266_abnormal_metabolism | 0.94058806 |
110 | MP0002088_abnormal_embryonic_growth/wei | 0.92654989 |
111 | MP0008932_abnormal_embryonic_tissue | 0.91186085 |
112 | MP0002075_abnormal_coat/hair_pigmentati | 0.90312057 |
113 | MP0004381_abnormal_hair_follicle | 0.89322532 |
114 | MP0002095_abnormal_skin_pigmentation | 0.88626371 |
115 | MP0000371_diluted_coat_color | 0.88412608 |
116 | MP0000685_abnormal_immune_system | 0.88193238 |
117 | MP0005076_abnormal_cell_differentiation | 0.87801116 |
118 | MP0002210_abnormal_sex_determination | 0.87216726 |
119 | MP0008872_abnormal_physiological_respon | 0.86870248 |
120 | MP0005367_renal/urinary_system_phenotyp | 0.86821341 |
121 | MP0000516_abnormal_urinary_system | 0.86821341 |
122 | MP0001730_embryonic_growth_arrest | 0.85198953 |
123 | MP0005025_abnormal_response_to | 0.84242734 |
124 | MP0000358_abnormal_cell_content/ | 0.84034792 |
125 | MP0002653_abnormal_ependyma_morphology | 0.83381708 |
126 | MP0002429_abnormal_blood_cell | 0.82153385 |
127 | MP0000716_abnormal_immune_system | 0.78543057 |
128 | MP0003635_abnormal_synaptic_transmissio | 0.77761532 |
129 | MP0001191_abnormal_skin_condition | 0.76747552 |
130 | MP0002085_abnormal_embryonic_tissue | 0.76704056 |
131 | MP0003943_abnormal_hepatobiliary_system | 0.76680378 |
132 | MP0001919_abnormal_reproductive_system | 0.75579734 |
133 | MP0005376_homeostasis/metabolism_phenot | 0.73865494 |
134 | MP0001819_abnormal_immune_cell | 0.73507611 |
135 | MP0008469_abnormal_protein_level | 0.72962692 |
136 | MP0001756_abnormal_urination | 0.72380130 |
137 | MP0001929_abnormal_gametogenesis | 0.72061803 |
138 | MP0002420_abnormal_adaptive_immunity | 0.71516015 |
139 | MP0010771_integument_phenotype | 0.71426401 |
140 | MP0001145_abnormal_male_reproductive | 0.71175178 |
141 | MP0000598_abnormal_liver_morphology | 0.71075196 |
142 | MP0002419_abnormal_innate_immunity | 0.70609896 |
143 | MP0002166_altered_tumor_susceptibility | 0.70415501 |
144 | MP0005410_abnormal_fertilization | 0.70320167 |
145 | MP0003448_altered_tumor_morphology | 0.70072890 |
146 | MP0004215_abnormal_myocardial_fiber | 0.70069064 |
147 | MP0000703_abnormal_thymus_morphology | 0.69882547 |
148 | MP0002086_abnormal_extraembryonic_tissu | 0.69587986 |
149 | MP0003698_abnormal_male_reproductive | 0.69461783 |
150 | MP0005171_absent_coat_pigmentation | 0.69383899 |
151 | MP0009278_abnormal_bone_marrow | 0.69112386 |
152 | MP0002019_abnormal_tumor_incidence | 0.68851503 |
153 | MP0005394_taste/olfaction_phenotype | 0.68371726 |
154 | MP0005499_abnormal_olfactory_system | 0.68371726 |
155 | MP0004808_abnormal_hematopoietic_stem | 0.68096580 |
156 | MP0001984_abnormal_olfaction | 0.67323103 |
157 | MP0000465_gastrointestinal_hemorrhage | 0.67081046 |
158 | MP0004270_analgesia | 0.65658254 |
159 | MP0005058_abnormal_lysosome_morphology | 0.65147529 |
160 | MP0000759_abnormal_skeletal_muscle | 0.65056045 |
161 | MP0002277_abnormal_respiratory_mucosa | 0.64304735 |
162 | MP0000003_abnormal_adipose_tissue | 0.61310003 |
163 | MP0008873_increased_physiological_sensi | 0.60095988 |
164 | MP0009931_abnormal_skin_appearance | 0.59517280 |
165 | MP0001293_anophthalmia | 0.58678482 |
166 | MP0000653_abnormal_sex_gland | 0.58084997 |
167 | MP0005409_darkened_coat_color | 0.56156757 |
168 | MP0004264_abnormal_extraembryonic_tissu | 0.55854520 |
169 | MP0001216_abnormal_epidermal_layer | 0.55546471 |
170 | MP0002735_abnormal_chemical_nociception | 0.55054920 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Testicular atrophy (HP:0000029) | 5.50491498 |
2 | Poikiloderma (HP:0001029) | 5.49121017 |
3 | Dyschromatopsia (HP:0007641) | 4.91408540 |
4 | Hepatocellular necrosis (HP:0001404) | 4.87317673 |
5 | Hepatic necrosis (HP:0002605) | 4.46964127 |
6 | Facial hemangioma (HP:0000329) | 4.45458350 |
7 | Selective tooth agenesis (HP:0001592) | 4.32527707 |
8 | Squamous cell carcinoma (HP:0002860) | 4.27065145 |
9 | Increased CSF lactate (HP:0002490) | 4.12950036 |
10 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 4.05673360 |
11 | Abnormality of glycolysis (HP:0004366) | 4.04260578 |
12 | Increased serum pyruvate (HP:0003542) | 4.04260578 |
13 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.86634397 |
14 | Mitochondrial inheritance (HP:0001427) | 3.76127879 |
15 | Increased serum lactate (HP:0002151) | 3.73487779 |
16 | Basal cell carcinoma (HP:0002671) | 3.67981928 |
17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.65290181 |
18 | Ragged-red muscle fibers (HP:0003200) | 3.60636089 |
19 | Reduced antithrombin III activity (HP:0001976) | 3.53671175 |
20 | Popliteal pterygium (HP:0009756) | 3.46779331 |
21 | Rectovaginal fistula (HP:0000143) | 3.45133327 |
22 | Rectal fistula (HP:0100590) | 3.45133327 |
23 | Attenuation of retinal blood vessels (HP:0007843) | 3.42779016 |
24 | Acute necrotizing encephalopathy (HP:0006965) | 3.41612491 |
25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.40744454 |
26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.40744454 |
27 | Akinesia (HP:0002304) | 3.39036474 |
28 | Hypothermia (HP:0002045) | 3.38614754 |
29 | Progressive macrocephaly (HP:0004481) | 3.32407039 |
30 | Abnormality of alanine metabolism (HP:0010916) | 3.30306554 |
31 | Hyperalaninemia (HP:0003348) | 3.30306554 |
32 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.30306554 |
33 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.29297793 |
34 | Lactic acidosis (HP:0003128) | 3.28156289 |
35 | Rib fusion (HP:0000902) | 3.26596462 |
36 | Vaginal fistula (HP:0004320) | 3.26579581 |
37 | Type I transferrin isoform profile (HP:0003642) | 3.25158033 |
38 | Ulnar bowing (HP:0003031) | 3.23776432 |
39 | Amniotic constriction ring (HP:0009775) | 3.19131395 |
40 | Abnormality of placental membranes (HP:0011409) | 3.19131395 |
41 | Neonatal respiratory distress (HP:0002643) | 3.16378753 |
42 | Facial diplegia (HP:0001349) | 3.15751918 |
43 | Anteriorly placed anus (HP:0001545) | 3.15674114 |
44 | Acute encephalopathy (HP:0006846) | 3.14375559 |
45 | Fetal akinesia sequence (HP:0001989) | 3.05519223 |
46 | Intestinal fistula (HP:0100819) | 3.04088098 |
47 | Cholelithiasis (HP:0001081) | 2.98205388 |
48 | Microvesicular hepatic steatosis (HP:0001414) | 2.94090703 |
49 | Increased intramyocellular lipid droplets (HP:0012240) | 2.93336621 |
50 | Cutaneous melanoma (HP:0012056) | 2.92439431 |
51 | Progressive external ophthalmoplegia (HP:0000590) | 2.89728080 |
52 | Aplastic anemia (HP:0001915) | 2.86231917 |
53 | Choroideremia (HP:0001139) | 2.77061952 |
54 | Neoplasm of the adrenal gland (HP:0100631) | 2.75314854 |
55 | Poor suck (HP:0002033) | 2.75133276 |
56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.73461397 |
57 | Aplasia of the musculature (HP:0100854) | 2.73088649 |
58 | Entropion (HP:0000621) | 2.69313712 |
59 | Increased muscle lipid content (HP:0009058) | 2.67083853 |
60 | Thin bony cortex (HP:0002753) | 2.65123253 |
61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.64967028 |
62 | Long clavicles (HP:0000890) | 2.63857004 |
63 | Thyroid-stimulating hormone excess (HP:0002925) | 2.60450817 |
64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.59244389 |
65 | Abnormal gallbladder morphology (HP:0012437) | 2.59178722 |
66 | Exercise intolerance (HP:0003546) | 2.57812666 |
67 | Shoulder girdle muscle weakness (HP:0003547) | 2.56222689 |
68 | Lipid accumulation in hepatocytes (HP:0006561) | 2.55391680 |
69 | Cerebral edema (HP:0002181) | 2.54114895 |
70 | Conjunctival hamartoma (HP:0100780) | 2.53497119 |
71 | Patellar aplasia (HP:0006443) | 2.50828587 |
72 | Capillary hemangiomas (HP:0005306) | 2.44742925 |
73 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.40834025 |
74 | Abnormal number of erythroid precursors (HP:0012131) | 2.39411725 |
75 | Annular pancreas (HP:0001734) | 2.39218028 |
76 | CNS demyelination (HP:0007305) | 2.38676644 |
77 | Respiratory failure (HP:0002878) | 2.37419158 |
78 | Respiratory difficulties (HP:0002880) | 2.35051174 |
79 | Poor head control (HP:0002421) | 2.35000612 |
80 | Epiphyseal stippling (HP:0010655) | 2.34840445 |
81 | Premature graying of hair (HP:0002216) | 2.30909341 |
82 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.28342221 |
83 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.28342221 |
84 | Abnormal protein glycosylation (HP:0012346) | 2.28342221 |
85 | Abnormal glycosylation (HP:0012345) | 2.28342221 |
86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.28247039 |
87 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.28146577 |
88 | Hypoplastic pelvis (HP:0008839) | 2.27814999 |
89 | Hemorrhage of the eye (HP:0011885) | 2.27131726 |
90 | Myotonia (HP:0002486) | 2.27063531 |
91 | Opisthotonus (HP:0002179) | 2.26358603 |
92 | Emotional lability (HP:0000712) | 2.25965867 |
93 | Thrombocytosis (HP:0001894) | 2.25709009 |
94 | Type 2 muscle fiber atrophy (HP:0003554) | 2.24340693 |
95 | IgM deficiency (HP:0002850) | 2.24003388 |
96 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.22031516 |
97 | Myopathic facies (HP:0002058) | 2.21423426 |
98 | Unsteady gait (HP:0002317) | 2.21016320 |
99 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.18444978 |
100 | Mesangial abnormality (HP:0001966) | 2.15311271 |
101 | Pulmonary fibrosis (HP:0002206) | 2.14952705 |
102 | Tubulointerstitial nephritis (HP:0001970) | 2.14295739 |
103 | Diminished movement (HP:0002374) | 2.14106197 |
104 | Metabolic acidosis (HP:0001942) | 2.13954170 |
105 | Neuroendocrine neoplasm (HP:0100634) | 2.12254444 |
106 | Abnormal epiphyseal ossification (HP:0010656) | 2.11008213 |
107 | Turricephaly (HP:0000262) | 2.10991618 |
108 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.10885571 |
109 | Postnatal microcephaly (HP:0005484) | 2.10872024 |
110 | Oral leukoplakia (HP:0002745) | 2.08788267 |
111 | Lethargy (HP:0001254) | 2.07571158 |
112 | Gliosis (HP:0002171) | 2.07139895 |
113 | Absent radius (HP:0003974) | 2.06059671 |
114 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.05602370 |
115 | Abnormal spermatogenesis (HP:0008669) | 2.05263846 |
116 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.04058651 |
117 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.03252893 |
118 | Medulloblastoma (HP:0002885) | 2.01214654 |
119 | Hyperbilirubinemia (HP:0002904) | 1.98717670 |
120 | Malignant hyperthermia (HP:0002047) | 1.98025323 |
121 | Absent forearm bone (HP:0003953) | 1.97488308 |
122 | Aplasia involving forearm bones (HP:0009822) | 1.97488308 |
123 | Dicarboxylic aciduria (HP:0003215) | 1.96912872 |
124 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96912872 |
125 | Ependymoma (HP:0002888) | 1.95649561 |
126 | Cortical visual impairment (HP:0100704) | 1.95496641 |
127 | Exertional dyspnea (HP:0002875) | 1.92499958 |
128 | Pheochromocytoma (HP:0002666) | 1.91794165 |
129 | Muscle fiber atrophy (HP:0100295) | 1.91745781 |
130 | Hyperammonemia (HP:0001987) | 1.91165080 |
131 | Abnormality of serum amino acid levels (HP:0003112) | 1.90989410 |
132 | Prolonged partial thromboplastin time (HP:0003645) | 1.89942192 |
133 | Progressive muscle weakness (HP:0003323) | 1.89817630 |
134 | Birth length less than 3rd percentile (HP:0003561) | 1.89078307 |
135 | Hypoplasia of the thymus (HP:0000778) | 1.88870810 |
136 | Abnormal gallbladder physiology (HP:0012438) | 1.88231398 |
137 | Cholecystitis (HP:0001082) | 1.88231398 |
138 | Hypobetalipoproteinemia (HP:0003563) | 1.88004125 |
139 | Joint hemorrhage (HP:0005261) | 1.87959086 |
140 | Rimmed vacuoles (HP:0003805) | 1.86891352 |
141 | Progressive microcephaly (HP:0000253) | 1.86364532 |
142 | Horizontal nystagmus (HP:0000666) | 1.85451021 |
143 | Neoplasm of head and neck (HP:0012288) | 1.85357782 |
144 | Esophageal neoplasm (HP:0100751) | 1.85357782 |
145 | Chromsome breakage (HP:0040012) | 1.84955914 |
146 | Pelvic girdle muscle weakness (HP:0003749) | 1.84563483 |
147 | Renal Fanconi syndrome (HP:0001994) | 1.84492082 |
148 | Rhabdomyolysis (HP:0003201) | 1.84443129 |
149 | Abnormal trabecular bone morphology (HP:0100671) | 1.84261750 |
150 | Atrioventricular block (HP:0001678) | 1.84163679 |
151 | Hyperglycinemia (HP:0002154) | 1.83172876 |
152 | Myelodysplasia (HP:0002863) | 1.82924446 |
153 | Cortical dysplasia (HP:0002539) | 1.82840680 |
154 | Abnormality of the basal ganglia (HP:0002134) | 1.82279974 |
155 | Thin ribs (HP:0000883) | 1.81642873 |
156 | Optic nerve coloboma (HP:0000588) | 1.81397183 |
157 | Agnosia (HP:0010524) | 1.80865613 |
158 | 11 pairs of ribs (HP:0000878) | 1.78989288 |
159 | Exercise-induced muscle cramps (HP:0003710) | 1.78896685 |
160 | Mediastinal lymphadenopathy (HP:0100721) | 1.78262515 |
161 | Thyroiditis (HP:0100646) | 1.77980578 |
162 | Failure to thrive in infancy (HP:0001531) | 1.77748383 |
163 | Pancytopenia (HP:0001876) | 1.77105133 |
164 | B lymphocytopenia (HP:0010976) | 1.76929568 |
165 | Abnormality of B cell number (HP:0010975) | 1.76929568 |
166 | Vertebral compression fractures (HP:0002953) | 1.75785013 |
167 | Delayed epiphyseal ossification (HP:0002663) | 1.74868539 |
168 | Abnormal hair whorl (HP:0010721) | 1.74514962 |
169 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72769915 |
170 | Cystic hygroma (HP:0000476) | 1.70480221 |
171 | Optic disc pallor (HP:0000543) | 1.69408087 |
172 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.66348553 |
173 | Muscular hypotonia of the trunk (HP:0008936) | 1.66250785 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 5.53300120 |
2 | TRIM28 | 3.70659797 |
3 | TESK2 | 3.35861576 |
4 | STK16 | 3.23848347 |
5 | CCNB1 | 3.22478804 |
6 | FRK | 3.00729534 |
7 | TTK | 2.91206924 |
8 | PRPF4B | 2.90120791 |
9 | TNIK | 2.89958778 |
10 | CDK19 | 2.89315250 |
11 | WEE1 | 2.83911178 |
12 | EIF2AK1 | 2.78632286 |
13 | MAP3K12 | 2.75831165 |
14 | BCKDK | 2.59867942 |
15 | TSSK6 | 2.29283683 |
16 | PBK | 2.29083571 |
17 | BUB1 | 2.26162786 |
18 | BRSK2 | 2.15314353 |
19 | CASK | 2.13295229 |
20 | MAP2K7 | 2.04005423 |
21 | CDC7 | 1.92335160 |
22 | PDK4 | 1.92028875 |
23 | PDK3 | 1.92028875 |
24 | SRPK1 | 1.88631589 |
25 | VRK1 | 1.78768447 |
26 | DAPK1 | 1.78457978 |
27 | BCR | 1.77433141 |
28 | EIF2AK3 | 1.74264907 |
29 | FES | 1.67930297 |
30 | BRSK1 | 1.64512575 |
31 | NEK1 | 1.63798699 |
32 | TAOK2 | 1.61455574 |
33 | SCYL2 | 1.44679741 |
34 | SIK3 | 1.42580807 |
35 | NUAK1 | 1.36337104 |
36 | FLT3 | 1.35930845 |
37 | STK10 | 1.33871565 |
38 | CDK6 | 1.33003397 |
39 | KIT | 1.28678478 |
40 | CAMKK2 | 1.25173988 |
41 | TLK1 | 1.24965303 |
42 | PLK3 | 1.23076319 |
43 | ACVR1B | 1.20494996 |
44 | EPHB1 | 1.17290522 |
45 | MUSK | 1.16723266 |
46 | DYRK1B | 1.16577709 |
47 | YES1 | 1.16010131 |
48 | BLK | 1.12012846 |
49 | TESK1 | 1.10509488 |
50 | NME2 | 1.07620400 |
51 | NEK9 | 1.07480572 |
52 | EPHA2 | 1.05032781 |
53 | CDK8 | 1.01295138 |
54 | IRAK2 | 1.00422052 |
55 | MST4 | 0.98416753 |
56 | TGFBR1 | 0.98107743 |
57 | PIM2 | 0.97978177 |
58 | TEC | 0.97701379 |
59 | AURKA | 0.93101644 |
60 | MAP2K6 | 0.92607052 |
61 | CDK14 | 0.89475660 |
62 | SYK | 0.88755319 |
63 | NTRK3 | 0.86468193 |
64 | MAP2K4 | 0.85961528 |
65 | EPHA3 | 0.85059739 |
66 | MAP2K3 | 0.83674392 |
67 | GRK6 | 0.83541633 |
68 | PAK4 | 0.83276116 |
69 | PLK1 | 0.81360793 |
70 | MAP4K1 | 0.80833251 |
71 | ATR | 0.80409053 |
72 | MAP4K2 | 0.80320067 |
73 | AURKB | 0.78989280 |
74 | CLK1 | 0.77068911 |
75 | NEK6 | 0.76223763 |
76 | MAP3K4 | 0.75213044 |
77 | ERBB3 | 0.74379529 |
78 | MAP3K11 | 0.71842152 |
79 | ABL2 | 0.70195129 |
80 | TXK | 0.70070543 |
81 | PAK6 | 0.69421163 |
82 | ZAK | 0.68888309 |
83 | CSNK1G1 | 0.68678198 |
84 | VRK2 | 0.67987351 |
85 | CSNK1G3 | 0.67653490 |
86 | KDR | 0.66601516 |
87 | FGFR2 | 0.66226635 |
88 | ADRBK2 | 0.65486474 |
89 | MAPK4 | 0.64441798 |
90 | MAPK13 | 0.64378540 |
91 | BTK | 0.63774133 |
92 | MKNK1 | 0.62896489 |
93 | PRKD3 | 0.59836518 |
94 | PLK4 | 0.59751515 |
95 | NME1 | 0.58650890 |
96 | LYN | 0.56576442 |
97 | SIK2 | 0.56122398 |
98 | MYLK | 0.55518752 |
99 | CHEK1 | 0.54535736 |
100 | RPS6KA5 | 0.54208160 |
101 | CSNK1A1L | 0.53859719 |
102 | PAK1 | 0.52585449 |
103 | BMPR1B | 0.51845685 |
104 | DYRK3 | 0.51162579 |
105 | ZAP70 | 0.49249477 |
106 | CHEK2 | 0.48643400 |
107 | RAF1 | 0.46988700 |
108 | CSNK2A1 | 0.46973315 |
109 | EIF2AK2 | 0.46737473 |
110 | AKT2 | 0.45797252 |
111 | PLK2 | 0.44093730 |
112 | MELK | 0.43445170 |
113 | SMG1 | 0.43004273 |
114 | ERN1 | 0.43001680 |
115 | PINK1 | 0.42669924 |
116 | CSF1R | 0.41849357 |
117 | BMX | 0.41652258 |
118 | BRD4 | 0.41451552 |
119 | PRKD1 | 0.41389473 |
120 | PRKCG | 0.41292657 |
121 | ERBB4 | 0.40777068 |
122 | CDK7 | 0.40457429 |
123 | TAOK3 | 0.39891647 |
124 | TRIB3 | 0.39795555 |
125 | CSNK1G2 | 0.39776375 |
126 | LMTK2 | 0.39366050 |
127 | CDK4 | 0.39259284 |
128 | UHMK1 | 0.39040891 |
129 | CSNK2A2 | 0.38412430 |
130 | PASK | 0.38379982 |
131 | LATS1 | 0.38348240 |
132 | WNK3 | 0.38102873 |
133 | PIM1 | 0.37277954 |
134 | TBK1 | 0.36880446 |
135 | ATM | 0.36844580 |
136 | IKBKE | 0.36220559 |
137 | CDK1 | 0.35761911 |
138 | PRKCI | 0.35385321 |
139 | LIMK1 | 0.34999164 |
140 | CDK2 | 0.34516084 |
141 | MKNK2 | 0.32869989 |
142 | CDK18 | 0.32401315 |
143 | IRAK4 | 0.31998990 |
144 | BRAF | 0.30672120 |
145 | MAPK11 | 0.29478597 |
146 | PDK2 | 0.28109550 |
147 | RPS6KB1 | 0.27686067 |
148 | DAPK2 | 0.27330595 |
149 | ADRBK1 | 0.25972671 |
150 | TYK2 | 0.25533780 |
151 | CDK15 | 0.23405097 |
152 | CDK11A | 0.22745516 |
153 | PRKCD | 0.22001161 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.01221175 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.71379971 |
3 | DNA replication_Homo sapiens_hsa03030 | 3.64790230 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.92529232 |
5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.90855262 |
6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.67235920 |
7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50505043 |
8 | RNA polymerase_Homo sapiens_hsa03020 | 2.36661903 |
9 | Base excision repair_Homo sapiens_hsa03410 | 2.29122930 |
10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.23845224 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20150593 |
12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.16768990 |
13 | Mismatch repair_Homo sapiens_hsa03430 | 2.16671875 |
14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.07617300 |
15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.07078424 |
16 | Ribosome_Homo sapiens_hsa03010 | 2.06612634 |
17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.94578778 |
18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.93143054 |
19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.92364830 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.90288417 |
21 | Spliceosome_Homo sapiens_hsa03040 | 1.87259335 |
22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.87257288 |
23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.83479844 |
24 | Homologous recombination_Homo sapiens_hsa03440 | 1.81215071 |
25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.81043672 |
26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.73398037 |
27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.71027058 |
28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.57978859 |
29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54400898 |
30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53199361 |
31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46428534 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41382279 |
33 | Purine metabolism_Homo sapiens_hsa00230 | 1.39558757 |
34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37891111 |
35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.37008499 |
36 | Protein export_Homo sapiens_hsa03060 | 1.34526180 |
37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32879767 |
38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.30612052 |
39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.29540211 |
40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.29259860 |
41 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.24444145 |
42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21949952 |
43 | RNA degradation_Homo sapiens_hsa03018 | 1.21601973 |
44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18368442 |
45 | Nicotine addiction_Homo sapiens_hsa05033 | 1.16515171 |
46 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.15875509 |
47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14995999 |
48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.14986773 |
49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14246852 |
50 | RNA transport_Homo sapiens_hsa03013 | 1.11791737 |
51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10262152 |
52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.09404978 |
53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05562897 |
54 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03950909 |
55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01141965 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00433283 |
57 | Cell cycle_Homo sapiens_hsa04110 | 0.98595013 |
58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94999131 |
59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94699165 |
60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.92352318 |
61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90915339 |
62 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.90208713 |
63 | Peroxisome_Homo sapiens_hsa04146 | 0.88754480 |
64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86116468 |
65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84286126 |
66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.84020864 |
67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82494991 |
68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81056619 |
69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80134766 |
70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79436622 |
71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.79392321 |
72 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77947717 |
73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76651060 |
74 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.75042576 |
75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75039583 |
76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74829916 |
77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74355466 |
78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73634393 |
79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72163192 |
80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71156169 |
81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70594616 |
82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70491178 |
83 | Alcoholism_Homo sapiens_hsa05034 | 0.70484135 |
84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68286748 |
85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66592311 |
86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66341741 |
87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64399213 |
88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64129517 |
89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64055689 |
90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63011844 |
91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62935673 |
92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61844305 |
93 | Endocytosis_Homo sapiens_hsa04144 | 0.60321214 |
94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59232379 |
95 | Apoptosis_Homo sapiens_hsa04210 | 0.54959912 |
96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54765612 |
97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54388750 |
98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54288097 |
99 | Lysine degradation_Homo sapiens_hsa00310 | 0.53648622 |
100 | Hepatitis B_Homo sapiens_hsa05161 | 0.52706112 |
101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51386706 |
102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51252255 |
103 | Shigellosis_Homo sapiens_hsa05131 | 0.49500684 |
104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48592442 |
105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44311703 |
106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.44263909 |
107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41973092 |
108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40942713 |
109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37608639 |
110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35280985 |
111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35278435 |
112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34945489 |
113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34145747 |
114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33850204 |
115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33799701 |
116 | Lysosome_Homo sapiens_hsa04142 | 0.33282671 |
117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32801705 |
118 | Hepatitis C_Homo sapiens_hsa05160 | 0.32331885 |
119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31815269 |
120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31241219 |
121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30863636 |
122 | Legionellosis_Homo sapiens_hsa05134 | 0.29895682 |
123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.29434379 |
124 | Taste transduction_Homo sapiens_hsa04742 | 0.28819815 |
125 | Phototransduction_Homo sapiens_hsa04744 | 0.28225307 |
126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25828743 |
127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24365035 |
128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24261727 |
129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.24212166 |
130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24186263 |
131 | Measles_Homo sapiens_hsa05162 | 0.23706928 |
132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22304377 |
133 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.22088379 |
134 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.19798902 |
135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.19482109 |
136 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.18323561 |
137 | Retinol metabolism_Homo sapiens_hsa00830 | 0.16169968 |
138 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.16074699 |
139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12874593 |
140 | Phagosome_Homo sapiens_hsa04145 | 0.11008740 |
141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.10757974 |
142 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.10249232 |